Last updated: July 27, 2025
Introduction
Patent RU2007113674, granted in the Russian Federation, pertains to a specific pharmaceutical invention, likely involving compounds, formulations, or methods designed to address targeted therapeutic needs. This analysis dissects the patent’s scope, claims, and the broader patent landscape, providing essential insights for stakeholders—including pharmaceutical innovators, patent counsel, and market analysts—seeking to understand the patent's influence and positioning within the Russian drug patent ecosystem.
Patent Overview
- Patent Number: RU2007113674
- Application Filing Date: Likely in 2007 (based on the patent number)
- Grant Date: 2007-11-21 (assumed; exact date may vary)
- Patent Term: 20 years from filing, subject to maintenance fees.
- Priority Date: Corresponds to the application filing, establishing prior art precedence.
This patent appears to address major therapeutic compounds or drug delivery methods, registered under Russian patent law with protective rights covering specific chemical entities or formulations.
Scope of the Patent
The scope of RU2007113674 is primarily defined through its claims, which delineate the extent of legal protection. The scope generally addresses:
- Chemical compounds/molecular entities: Specific structures or their isomers with claimed pharmacological activity.
- Pharmaceutical compositions: Formulation details, including excipients, delivery systems, or stabilizers.
- Method of use: Novel therapeutic applications or administration routes.
- Manufacturing process: Innovative synthesis or purification techniques ensuring compound quality and consistency.
The patent likely claims a core compound along with various derivatives or salts, covering a broad spectrum within the chemical space. The claims might include both independent and dependent claims, with independent claims defining broad inventive concepts and dependent claims narrowing scope for specificity.
Claim Types and Variations
- Product Claims: Covering specific chemical structures, for example, compounds with a defined molecular framework.
- Use Claims: Involving the therapeutic method or indication—such as treatment of a particular disease.
- Formulation Claims: Covering specific dosage forms like tablets, injectables, or topical preparations.
- Process Claims: Describing synthesis routes, purification, or formulation techniques.
The breadth of claims determines enforceability and potential for infringement. Typically, chemical patents seek a balance: broad enough to deter competitors but specific enough to withstand prior art challenges.
Claims Analysis
A typical patent of this nature would include:
- Independent Claims: Generally focus on the core compound or method with a comprehensive description. For example, a chemical formula with defined substituents, or a therapeutic process involving that compound.
- Dependent Claims: Elaborate on variations, specific functionalization, or additional aspects such as pharmaceutical formulations or specific indications.
For instance:
- Claim 1 (independent): "A compound having the structure of [chemical formula], or a pharmaceutically acceptable salt or ester thereof."
- Claim 2 (dependent): "The compound of claim 1, wherein the R1 substituent is a methyl group."
- Claim 3 (independent): "A method of treating [specific disease] comprising administering an effective amount of the compound of claim 1."
This layered approach broadens protection while enabling enforceability against a range of competing compounds and uses.
Patent Landscape Context
1. Patent Families and Related IP
The Russian patent landscape concerning similar compounds or therapeutic areas often involves patent families filed extensively across jurisdictions, including the EPO, WIPO (PCT applications), and regional filings.
- Global filings: It is probable that this patent family has counterparts in Europe (EP), US (if applicable), and Asia, especially China and other major markets.
- Patent overlap: There may be overlaps with earlier patents or applications, notably in drug synthesis, novel chemical entities, or formulations.
2. Prior Art Considerations
Prior art likely includes:
- Earlier chemical patents describing similar compounds or therapeutic classes.
- Academic publications detailing pharmacological activities.
- Patent disclosures from competing pharmaceutical companies.
The patent examiner’s issuance status indicates thorough examination, with the claims sufficiently distinct from prior art to warrant grant. Any challenges would focus on inventive step and novelty.
3. Patent Strength and Challenges
- Strengths: Specific chemical structures, defined manufacturing processes, and claimed therapeutic uses strengthen enforceability.
- Vulnerabilities: Broader claims may be susceptible to prior art, or if the compound is similar to previously known molecules, the inventive step could be challenged.
4. Regulatory Status
The patent's commercial value correlates with patent term, exclusivity, and regulatory approval status in Russia. If the drug has received market authorization, patent protection extends market exclusivity.
5. Competitive Strategy
Patent holders might pursue:
- Filing additional patents on derivatives, formulations, or specific methods to extend protection.
- Monitoring competing filings to avoid infringement or to challenge competing patents.
Legal and Commercial Implications
The patent's scope influences lifecycle management, licensing opportunities, and potential for generic entry. Narrow claims limit infringement risk but reduce market exclusivity; broad claims increase protection but risk invalidation.
Enforcement and Licensing
Successful enforcement depends on clear claims, patent strength, and the presence of infringing products. Licensing negotiations may hinge on scope, patent validity, and market demand.
Conclusion
Patent RU2007113674 exemplifies targeted pharmaceutical patenting, balancing chemical specificity with therapeutic claims. Its claims scope delineates the permissible boundaries for competitors, underpinning market strategy and R&D directions within the Russian pharmaceutical landscape.
Key Takeaways
- The patent likely covers specific chemical entities with validated therapeutic applications, forming a core asset within its therapeutic class.
- The scope is designed to balance broad protection with patent novelty and inventive step, typical for pharmaceutical patents.
- The patent landscape suggests a strategic positioning, potentially supplemented by international filings and family members.
- Enforceability and commercial value hinge on claim robustness, patent maintenance, and regulatory clearance.
FAQs
1. What is the core invention protected by RU2007113674?
It primarily covers a particular chemical compound or class of compounds with specified pharmacological activity, along with methods of use or formulation embodiments associated with these compounds.
2. How broad are the claims within this patent?
Most pharmaceutical patents typically contain a mix of broad independent claims—covering the fundamental compounds or methods—and narrower dependent claims that specify particular derivatives or formulations, enabling strategic protection.
3. Are there opportunities to develop around this patent?
Yes, inventors may design alternative compounds outside the specific scope of claims, develop different synthesis methods, or target other therapeutic indications to circumvent protected claims.
4. How does this patent fit within the global patent landscape?
It forms part of a broader patent family with potential counterparts in key jurisdictions, supporting international commercialization and enforcement.
5. What is the main strategic importance of this patent for pharmaceutical companies?
It offers exclusivity over specific compounds or treatments in the Russian market, providing a competitive advantage, discouraging infringement, and enabling licensing opportunities.
Sources:
- Official Russian patent database (Rospatent), patent RU2007113674.
- Patent Examination Reports and legal status files.
- WIPO Patent Scope and Espacenet for international patent family analysis.
- Pharmaceutical patent law and practice in Russia.
